BELPHARMA

Company snapshot

BELPHARMA is an independent & privately owned pharmaceutical and biotech company. Our responsibility is to ensure continuity of access to patients & healthcare professionals to our portfolio of unique & targeted therapeutic solutions. Our operational focus is on the development of an international network of strategic alliances with reputable agents & on the operational management of commercial co

• 3 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for BELPHARMA. Not investment advice.

• What is BELPHARMA?

  Belpharma is a pharma organization headquartered in LUXEMBOURG, LU. Primary therapeutic focus areas include Apnea of Prematurity, Safety and Pharmacokinetics. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA

• Is BELPHARMA publicly traded?

  BELPHARMA appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does BELPHARMA develop or market?

  We link 2 drug profile(s) where BELPHARMA is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/belpharma-s-a#company-drugs.

• What are the latest developments for BELPHARMA?

  In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does BELPHARMA focus on?

  BELPHARMA focuses on Apnea of Prematurity, Safety and Pharmacokinetics based on our analysis of their pipeline programs and drug development activities.